Drugmakers’ Money-Back Guarantees: an Answer to Rising Prices or a ‘Carnival Game’?

Pharmaceutical companies are increasingly agreeing to refund money if patients don’t respond to medications as expected. The Trump administration is intrigued, but critics say the deals are unlikely to reduce consumers’ bills